SBM — Sirona Biochem Balance Sheet
0.000.00%
- CA$15.82m
- CA$19.10m
- CA$0.03m
Annual balance sheet for Sirona Biochem, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 3.73 | 1.54 | 0.778 | 0.422 | 0.571 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.457 | 0.496 | 0.443 | 0.797 | 0.444 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 4.26 | 2.1 | 1.26 | 1.27 | 1.02 |
Net Property, Plant And Equipment | — | 0.037 | 0.028 | 0.019 | 0.009 |
Total Assets | 4.26 | 2.14 | 1.29 | 1.29 | 1.03 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.92 | 1.03 | 0.741 | 0.865 | 1.87 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.07 | 2.09 | 1.38 | 1.08 | 3.54 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 2.19 | 0.047 | -0.097 | 0.215 | -2.51 |
Total Liabilities & Shareholders' Equity | 4.26 | 2.14 | 1.29 | 1.29 | 1.03 |
Total Common Shares Outstanding |